Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Shares of Cognizant are up 6.42% at $61.13. The company is worth $27.54B, number 462 out of 800 on our list.
The stock's 52-week band runs $36.86 to $85.48, and the latest print sits 28.5% under the top end of it.
In the quarter ended Jun 2026 the company brought in $5.48B of revenue, up 4.5% from a year earlier, with $636.00M of net profit (a 10.3% margin).
Valuation works out to 13.1 times trailing earnings, 20% below its five-year average of 16.4. The median for its industry group is 26.1.
17 analysts follow the stock and the average call is "buy". The mean target, $67.85, sits 11.0% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 4 factors below, ranked against the 800 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Higher trailing yield than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
17 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
CTSH is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-07-06, the strategy has returned 1524.8% (321.7% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $67.85, 11.0% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $82.03, so shares trade 25.5% below that estimate. On earnings multiple, it sits in the 7th percentile of its own five-year valuation range (cheaper than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 1, 2026 1:20 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 800 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 13.1x earnings, CTSH looks cheap against the market, and trades 50% below the 26.1x median among Software Outsourcing names. The two comparisons do not always agree.
$61.13 is the latest print for CTSH, a move of +6.42% against yesterday's close of $57.44. Today's low and high so far: $60.43 and $64.74.
Equity value comes to $27.54B at the current price. By that measure it is number 462 of the 800 names in our coverage.
Buyers pay 13.1 times the last twelve months of profit (EPS $4.56). Averaged over five years the multiple has been 16.4, and today's level ranks in the 7th percentile of its own history.
The year's floor is $36.86 and the ceiling $85.48. Shares are 28.5% away from that ceiling.
It does. Payouts over the past twelve months work out to a 2.09% yield; the latest ex-dividend date was August 18, 2026.
Of 17 analysts, 47% say buy, 53% hold and 0% sell. Price targets average $67.85, with the most cautious at $47.00 and the most optimistic at $103.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on CTSH.